Murphy Capital Management Inc Gsk PLC Transaction History

Murphy Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 22, 2019	SELL	$39.4 - $42.7 $194,045 - $210,297	-4,925 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$38.57 - $42.69 $189,957 - $210,248	4,925 New	4,925 $205,000
Q4 2018 Feb 04, 2019	SELL	$37.8 - $42.69 $214,514 - $242,265	-5,675 Closed	0 $0
Q3 2018 Oct 10, 2018	SELL	$39.75 - $42.69 $18,881 - $20,277	-475 Reduced 7.72%	5,675 $227,000
Q2 2018 Jul 26, 2018	SELL	$39.61 - $42.76 $1,980 - $2,138	-50 Reduced 0.81%	6,150 $247,000
Q1 2018 Apr 17, 2018	SELL	$36.18 - $40.15 $9,045 - $10,037	-250 Reduced 3.88%	6,200 $242,000
Q4 2017 Jan 29, 2018	BUY	$35.34 - $41.9 $44,175 - $52,375	1,250 Added 24.04%	6,450 $228,000
Q3 2017 Oct 19, 2017	BUY	$39.44 - $41.55 $205,088 - $216,059	5,200	5,200 $211,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Murphy Capital Management Inc with notifications on news.